RebelBio

RebelBio is a London-based pre-seed venture capital program that invests in biotech, healthtech, and life sciences startups. As the world's first life sciences accelerator, RebelBio has accelerated 78 biotech startups and has since merged with SOSV's IndieBio brand in New York City. The program offers funding, co-working space, mentorship, and access to a network of alumni, investors, corporate partners, and media partners. RebelBio began in 2014 in Cork, Ireland, and relocated to the Imperial College of London in 2018 for a more business-friendly environment. In 2020, it merged with SOSV's IndieBio brand and is now based in New York City. During the accelerator program, startup teams compete to be selected. Once selected, each team member is referred to as a 'rebel' for the duration of the program. The teams head to Imperial College London for RebelBio's three-month accelerator program. Their accelerator program encourages scientists to participate and attempts to transform them into entrepreneurs. Each accelerator cohort finishes with Investor Month, a month where teams get to pitch their businesses to investors in hope of receiving more funding and creating important business connections.

Biotech startups, Healthtech startups, Life sciences startups, Pre-seed stage, Seed stage